JP2018501241A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018501241A5 JP2018501241A5 JP2017532859A JP2017532859A JP2018501241A5 JP 2018501241 A5 JP2018501241 A5 JP 2018501241A5 JP 2017532859 A JP2017532859 A JP 2017532859A JP 2017532859 A JP2017532859 A JP 2017532859A JP 2018501241 A5 JP2018501241 A5 JP 2018501241A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- subject
- use according
- derived
- msc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 22
- 210000004027 cell Anatomy 0.000 claims 11
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims 10
- 241001465754 Metazoa Species 0.000 claims 5
- 230000028327 secretion Effects 0.000 claims 5
- 208000027866 inflammatory disease Diseases 0.000 claims 4
- 210000000130 stem cell Anatomy 0.000 claims 4
- 238000004113 cell culture Methods 0.000 claims 2
- 201000008482 osteoarthritis Diseases 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 241000282465 Canis Species 0.000 claims 1
- 241000283073 Equus caballus Species 0.000 claims 1
- 241000282324 Felis Species 0.000 claims 1
- 241000288906 Primates Species 0.000 claims 1
- 241000283984 Rodentia Species 0.000 claims 1
- 241000282898 Sus scrofa Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 230000000735 allogeneic effect Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 210000004271 bone marrow stromal cell Anatomy 0.000 claims 1
- 210000004700 fetal blood Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 210000002826 placenta Anatomy 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022035174A JP2022069524A (ja) | 2014-12-19 | 2022-03-08 | 改良された細胞療法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2014905157A AU2014905157A0 (en) | 2014-12-19 | Improved cell-based therapies | |
| AU2014905156A AU2014905156A0 (en) | 2014-12-19 | Improved cell therapies | |
| AU2014905157 | 2014-12-19 | ||
| AU2014905156 | 2014-12-19 | ||
| AU2015901929A AU2015901929A0 (en) | 2015-05-26 | Improved cell therapies | |
| AU2015901929 | 2015-05-26 | ||
| PCT/AU2015/000755 WO2016094932A1 (en) | 2014-12-19 | 2015-12-18 | Improved cell therapies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022035174A Division JP2022069524A (ja) | 2014-12-19 | 2022-03-08 | 改良された細胞療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018501241A JP2018501241A (ja) | 2018-01-18 |
| JP2018501241A5 true JP2018501241A5 (cg-RX-API-DMAC7.html) | 2019-02-07 |
Family
ID=56125431
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017532859A Pending JP2018501241A (ja) | 2014-12-19 | 2015-12-18 | 改良された細胞療法 |
| JP2022035174A Pending JP2022069524A (ja) | 2014-12-19 | 2022-03-08 | 改良された細胞療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022035174A Pending JP2022069524A (ja) | 2014-12-19 | 2022-03-08 | 改良された細胞療法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20180221411A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3233097A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2018501241A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015367275B2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016094932A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018225440A1 (ja) * | 2017-06-09 | 2018-12-13 | 国立大学法人大阪大学 | 拡張型心筋症治療剤 |
| JP2020533373A (ja) * | 2017-09-15 | 2020-11-19 | サイナータ セラピューティクス リミテッド | アレルギー性気道疾患（ａａｄ）／喘息の処置方法 |
| US10702547B2 (en) * | 2018-05-16 | 2020-07-07 | Aq Skin Solutions Inc. | Compositions for treatment of arthritis |
| EP3806872A1 (en) * | 2018-06-15 | 2021-04-21 | Mariñas Pardo, Luis | Pharmaceutical composition for dermatology and uses thereof |
| KR20240034745A (ko) * | 2021-07-08 | 2024-03-14 | 베링거 인겔하임 베터리너리 메디슨 벨기에 | 동물의 골관절염 치료용 중간엽 줄기세포 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013205140A1 (en) * | 2008-08-22 | 2013-05-16 | Regeneus Ltd. | Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes |
| AU2010347212B2 (en) | 2010-09-14 | 2016-07-14 | Cell Ideas Pty Ltd | Cell free preparation and uses thereof |
| CA2863556A1 (en) * | 2011-01-31 | 2012-08-09 | Henry E. Young | Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease |
| WO2013040649A1 (en) | 2011-09-23 | 2013-03-28 | Cell Ideas Pty Ltd | Therapeutics using adipose cells and cell secretions |
| US9782440B2 (en) * | 2012-02-16 | 2017-10-10 | The Cleveland Clinic Foundation | Methods for treating genitourinary disorders |
-
2015
- 2015-12-18 EP EP15868687.3A patent/EP3233097A4/en not_active Withdrawn
- 2015-12-18 JP JP2017532859A patent/JP2018501241A/ja active Pending
- 2015-12-18 AU AU2015367275A patent/AU2015367275B2/en not_active Ceased
- 2015-12-18 US US15/537,427 patent/US20180221411A1/en not_active Abandoned
- 2015-12-18 WO PCT/AU2015/000755 patent/WO2016094932A1/en not_active Ceased
-
2022
- 2022-03-08 JP JP2022035174A patent/JP2022069524A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gugjoo et al. | Equine mesenchymal stem cells: properties, sources, characterization, and potential therapeutic applications | |
| Markoski | Advances in the use of stem cells in veterinary medicine: from basic research to clinical practice | |
| Matsuura et al. | Cell sheet approach for tissue engineering and regenerative medicine | |
| JP2018501241A5 (cg-RX-API-DMAC7.html) | ||
| Lange-Consiglio et al. | Conditioned medium from horse amniotic membrane-derived multipotent progenitor cells: immunomodulatory activity in vitro and first clinical application in tendon and ligament injuries in vivo | |
| Hall et al. | Early embryonic development, assisted reproductive technologies, and pluripotent stem cell biology in domestic mammals | |
| CL2011001984A1 (es) | Composicion seca estabilizadora para material biologico que comprende carbohidrato, proteinas hidrolizadas de animal o de planta y un componente de acido carboxilico; metodo de preparacion; y formulacion de entrega oral que comprende la composicion seca estabilizadora. | |
| JP2014527821A5 (cg-RX-API-DMAC7.html) | ||
| MX2020005849A (es) | Células madre y progenitoras hematopoyéticas humanas cd34+ modificadas con crispr-cas9 y sus usos. | |
| MX385015B (es) | Suplemento alimenticio. | |
| EP3943092A3 (en) | Compositions for use in inducing differentiation of human brown adipocyte progenitors | |
| GB2562406A (en) | A method of non destructive monitoring of biological processes in microfluidic tissue culture systems | |
| JP2015205894A5 (cg-RX-API-DMAC7.html) | ||
| BR112013028257A2 (pt) | "composição de fármaco biológico, métodos de manipulação de uma composição de fármaco biológica com células vivas e de fornecer composições de células vivas em um ponto de instalação de tratamento, bem como uso de células vivas formuladas em tampão não nutritivo" | |
| MX2019014578A (es) | Celulas renales bioactivas inmunoprivilegiadas para el tratamiento de enfermedad renal. | |
| BR112016002385A2 (pt) | animal não humano, célula, tecido ou embrião, vetor de alvejamento, constructo de vetor de alvejamento, e, métodos para produzir um animal não humano e para modificar um lócus de incrna em uma célula pluripotente | |
| Lara et al. | Endometrial stem cells in farm animals: potential role in uterine physiology and pathology | |
| Svoradova et al. | Chicken mesenchymal stem cells and their applications: a mini review | |
| Leal Reis et al. | Allogenic synovia-derived mesenchymal stem cells for treatment of equine tendinopathies and desmopathies—Proof of concept | |
| Yadav et al. | Fetal stem cells in farm animals: applications in health and production | |
| Zakirova et al. | Case of applying allogenic mesenchymal stem cells of adipogenic origin in veterinary dentistry | |
| Yushkov et al. | Stem-Cell Niches in Health and Disease: Microenvironmental Determinants of Regeneration and Pathology | |
| BR112016012285A2 (pt) | composições imunogênicas e vacinas derivadas de proteínas receptoras de superfície bacteriana | |
| MX2019010829A (es) | Metodos y composiciones para suministrar agentes activos de acido micofenolico a mamiferos no humanos. | |
| Bhaskar et al. | Applications of Stem cells Technology in Livestock Production |